finasteride has been researched along with Neoplasm Metastasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andriole, G; Boake, R; Crawford, D; DeKernion, J; Kadmon, D; Lieber, M; Rajfer, J; Schroeder, F; Smith, J; Soloway, M | 1 |
| Schlegel, PN | 1 |
| Nightingale, SL | 1 |
1 trial(s) available for finasteride and Neoplasm Metastasis
| Article | Year |
|---|---|
Treatment with finasteride following radical prostatectomy for prostate cancer.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms | 1995 |
2 other study(ies) available for finasteride and Neoplasm Metastasis
| Article | Year |
|---|---|
Prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Aged; Anticarcinogenic Agents; Disease-Free Survival; Estrogens; Finasteride; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasm Staging; Prevalence; Prostate-Specific Antigen; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Radiotherapy | 1994 |
From the Food and Drug Administration.
Topics: 5-alpha Reductase Inhibitors; Alkaloids; Androstenes; Antineoplastic Agents, Phytogenic; Azasteroids; Female; Finasteride; Humans; Male; Mammaplasty; Neoplasm Metastasis; Ovarian Neoplasms; Paclitaxel; Prostatic Hyperplasia; Prostheses and Implants; Silicones; United States; United States Food and Drug Administration | 1992 |